Table 1 Frequency of HLA–DR phenotypes in Japanese patients with autoimmune hepatitis
From: Evaluation of the role of HLA-DR antigens in Japanese type 1 autoimmune hepatitis
HLA–DR phenotype | Autoimmune hepatitis (n = 132) | Control subjects (n = 31973) | P–value | Odds ratio (95 % Cl) |
|---|---|---|---|---|
1 | 16 (11.9 %) | 3645 (11.4 %) | 0.795 | 1.07 (0.63–1.81) |
4 | 80 (59.7 %) | 13365 (41.8 %) | <0.001 | 2.14 (1.51–3.04) |
7 | 1 (0.7 %) | 239 (0.75 %) | 0.622 | 1.01 (0.14–7.28) |
8 | 38 (28.4 %) | 7513 (23.5 %) | 0.153 | 1.32 (0.90–1.92) |
9 | 27 (20.1 %) | 8505 (26.6 %) | 0.111 | 0.71 (0.46–1.08) |
11 | 2 (1.5 %) | 1644 (5.143 %) | 0.092 | 0.28 (0.07–1.15) |
12 | 8 (6.0 %) | 3485 (10.9 %) | 0.100 | 0.53 (0.26–1.08) |
13 | 14 (10.4 %) | 4029 (12.6 %) | 0.577 | 0.82 (0.44–1.43) |
14 | 25 (18.7 %) | 4348 (13.6 %) | 0.074 | 1.48 (0.96–2.30) |
15 | 34 (25.4 %) | 10647 (33.3 %) | 0.066 | 0.69 (0.47–1.03) |
16 | 3 (2.2 %) | 575 (1.8 %) | 0.935 | 1.27 (0.40–4.00) |
17 | 1 (0.7 %) | 88 (0.28 %) | 0.824 | 2.77 (0.38–20.0) |
6 *1 | 3 (2.2 %) | – |  |  |